Showing results (1-10 of 494) with videos related to
Sort By:
Pageof 50
Expert Opinion on Pharmacotherapy|July 17, 2008
Major bleeding: management and risk reduction in acute coronary syndromesMatthew A Cavender, Sunil V Rao, E Magnus OhmanAmerican Heart Journal|December 5, 2009
Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery diseaseMatthew A Cavender, Karen P Alexander, Samuel Broderick, et al.Diabetes, Obesity & Metabolism|July 3, 2026
Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult-to-Control Hypertension: An Overview for Primary Care PhysiciansMatthew A CavenderCirculation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.Current Interventional Cardiology Reports|November 7, 2001
'Facilitated' PCI for Acute MI: PCI with Lysis and Platelet InhibitionWarren J. Cantor, E. Magnus OhmanNature Reviews. Cardiology|October 7, 2015
Biomarkers: Troponin testing--risk stratification to stratified medicineL Kristin Newby, E Magnus OhmanLancet (London, England)|September 4, 2015
Pharmacological and emerging therapies in the treatment of chronic anginaSteen E Husted, E Magnus OhmanAnnual Review of Medicine|November 28, 2018
Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial FibrillationAlexander C Fanaroff, E Magnus OhmanThe Journal of Family Practice|July 13, 2017
Effect of non-insulin-based glucose-lowering therapies on cardiovascular outcomes in patients with type 2 diabetesSzymon L Wiernek, Matthew A CavenderJournal of Thrombosis and Thrombolysis|May 14, 2010
Bleeding associated with current therapies for acute coronary syndrome: what are the mechanisms?Matthew A Cavender, Sunil V RaoPageof 50